Experts on NIH COVID Panel Have Financial Ties to Gilead

Perhaps it’s not a big deal, but perhaps it is, at best, a conflict of interest.

Eight members of the National Institute of Health’s COVID-19 Treatment Guidelines Panel have financial ties to Gilead Sciences, the main company behind the production and testing of the drug, Remdesivir.

Remdesivir is the COVID-19 drug that has been touted by the director of the NIAID (National Institute of Allergy and Infectious Diseases), Anthony Fauci, as the top prospect for treating the virus.

The U.S. has reportedly bought almost all of the supply of Remdesivir from Gilead Sciences and Gilead has applied for FDA approval of the drug.

Dr. Fauci said the drug has set the new standard of care for the virus.

"And all of the other trials that are taking place now have a new standard of care," said Fauci.

However, Dr. William O'Neill, a cardiologist and Medical Director at the Henry Ford Health Systems (that touted the benefits of a large study of another drug, hydroxychloroquine) said he's not impressed with what he's seen from Remdesivir to date.

"There is a lot of hype for the drug," said O'Neil, adding that he sees "no big benefit" to remdesivir after reading medical journal reports on it.

Just The News also notes, from the  Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document, that 2 other experts on the panel have ties to Merck, who is conducting clinical trials for a vaccine for COVID-19.

Does this mean it's crooked or corrupt?

No, it doesn't.

But, it's not a good look given the fact that Remdesivir is said to cost around $3,120 for a course of treatment that has an estimated cost to produce of $9.32.

There are research and development costs as well as a cost to produce at an expedited rate, but Gilead also received about $70 million in taxpayer dollars as well as assistance from the NIH to run clinical trials. And according to this Politico article, Gilead spent $2.45 million lobbying the Senate in Q1 of 2020. That's more than ever before.

Some of the other drugs that have been touted by doctors around the world have a cost as low as $100 for a course of treatment due to the fact that the patent has long since expired and can be produced by virtually any company. Now, perhaps they really don't work that well but I, and a lot of other people, don't feel we've been allowed to have an open and honest conversation about that. In fact, you can be banned from social media for discussing certain drugs as a possible treatment for COVID-19.

After all, if the chosen drug is not affordable it can't be very effective. And, let's face it, the level of trust in the CDC, WHO, & NIH is anywhere but at an all-time high.

Perhaps the financial ties of panel members to the pharmaceutical manufacturers really isn't a big deal, but it certainly gives the appearance of a conflict of interest.

When you sign up to comment you'll also receive our regular newsletter. You can find more about how we use your information here.

Leave a Reply

Your email address will not be published. Required fields are marked *

7 thoughts on “Experts on NIH COVID Panel Have Financial Ties to Gilead”

  1. Why is this still news? The public has become accustomed to the graft and greed; and secure in the knowledge that there’s always some sort of financial tie-in to anything in Washington, and that goes for these folks too.
    It’s the reason we can’t DO ANYTHING without a damn mask, or go to work.
    All the grifters that are making our lives miserable, are not affected by their decisions. They keep getting huge salaries, and go about their day without worry. They also do NOT abide by their draconian orders . . . Mask for thee, but not me. “Don’t worry about what I do, just do what I say.”
    The only reason we’re still under this ‘COVID’ crap is because they are hoping for a profit, or a screwed up election.

  2. It’s about time! I’ve known that there were financial incentives for Hydroxychloroquine (HCQ) ($10) to be pushed aside and Remdesivir by Gilead (at $3300.00) to be pushed on us. Fauci has been dumping on hydroxy and pushing Remdesivir. The HCQ combo has had a 0.5% rate of side effects (minor like headache, upset stomach) and has been used 55 years and on some very vulnerable patients dropping the death rate by 50% or more. Remdesivir, causes 25% of patients to suffer side effects of MULTI organ failure, kidney damage, liver damage, low blood pressure and toxic shock. (This info is from Gilead’s OWN report on their OWN med, read LAST paragraph) It can drop the HOSPITALIZATION by 3 or 4 days. (not much benefit) WHY in the world would ANYONE choose to use Remdesivir?? My Dr and I discussed a plan for me back in March with the research we’d done (I’m an RN) and this was BEFORE Remdesivir was even out or Trump had said anything! But censorship intervened and now The HCQ combo is shunned and Remdesivir applauded. Americans, speak with your Drs. Research it yourself. Most of the studies DUMPING HCQ were faulty. Example; the one in Brazil was using 2000mg 3x per day. Talk about OVERDOSE! The standard dose is 200mg 2xper day. Heck, you can overdose on tylenol and HCQ is safer than tylenol.


  3. Remdesivir and Anthony Fauci can go pound sand! If people were given access to hydroxychloroquine, If FDA would give this drug over the counter status .You would not be wearing masks and business could re-open as normal!
    Why not to much money at steak for big Phama! Look at science of Malaria ,by CDC? hydroxychloroquine,look at what they said about safety. Make up your own minds.